PF4 and breast carcinoma: Even though the binding mechanism of RTO and KKO antibodies to breast cancer cells remains unclear, the RTO is known to bind only to a single PF4 monomer while the KKO is intercalated in between two PF4 monomers in a PF4/H complex [53].